Healthcare & Pharmaceuticals · Anglo-French Drugs & Industries Ltd Unlisted / Pre-IPO Share Price
The Anglo-French Drugs & Industries Ltd unlisted share price is quoted on request. Anglo-French Drugs & Industries Ltd is an unlisted / pre-IPO company — not listed on NSE or BSE.
Key figures for Anglo-French Drugs & Industries Ltd
Anglo-French Drugs & Industries Limited is a Public joined on 01 February 1923. It is delegated to a Non-govt organization and is enrolled at Registrar of Companies, Bangalore. Its approved offer capital is Rs. 20,000,000 and its settled up capital is Rs. 12,915,000. It is involved in the Manufacture of other synthetic items The Company produces and cycles nutrients, anti-epileptics, anti-oxidants, sleep-inducing agents, cold and cough preparations, protein food supplements, digestive enzymes, and calcium supplements AFDIL serves customers around the world. Anglo-French Drugs & Industries Limited's Annual General Meeting (AGM) was keep going hung on 29 September 2020 and according to records from the Ministry of Corporate Affairs (MCA), its asset report was kept going documented on 31 March 2020.
Anglo-French Drugs & Industries Ltd shares are unlisted, so they are bought off-market through a SEBI-registered intermediary rather than on the NSE or BSE. With Safal Capital the process is simple:
No. Anglo-French Drugs & Industries Ltd is currently an unlisted / pre-IPO company, so its shares are not traded on the NSE or BSE and there is no live “Anglo-French Drugs & Industries Ltdshare price NSE”. They are transacted off-market between buyers and sellers through SEBI-registered intermediaries such as Safal Capital.
Anglo-French Drugs & Industries Ltd has not announced a confirmed IPO date. Investors buy unlisted shares ahead of a potential listing for pre-IPO upside, but a listing is never guaranteed and timelines can change. Contact our desk for the latest status and a live quote before you invest.
Safal Capital tracks Anglo-French Drugs & Industries Ltd for pricing updates, liquidity context, and investor suitability.
Leave your name and mobile, our unlisted shares desk will call you back with live pricing and availability.
Latest source-linked updates that may be relevant to this company.
Solid Listing On Cards? SRIT India IPO GMP Signals 23% Gains As Issue Gets Fully Subscribed NDTV Profit
Srit India IPO fully bid on day 1 Business Standard
Anglo-French Drugs & Industries Ltd is an unlisted / pre-IPO company and its share price is indicative and quoted on request. Contact the Safal Capital desk for the latest Anglo-French Drugs & Industries Ltd unlisted share price and availability.
You buy Anglo-French Drugs & Industries Ltd unlisted shares off-market through a SEBI-registered intermediary. With Safal Capital: (1) share your requirement and quantity, (2) we confirm the live price and availability, (3) you complete KYC, (4) transfer funds, and (5) the shares are credited to your demat account, usually within T+1 to T+2 working days.
No. Anglo-French Drugs & Industries Ltd is currently an unlisted / pre-IPO company, so its shares are not traded on the NSE or BSE. They are transacted off-market between buyers and sellers through SEBI-registered intermediaries such as Safal Capital.
Anglo-French Drugs & Industries Ltd has not announced a confirmed IPO date. Unlisted shares are often bought before a potential listing in the hope of pre-IPO gains, but a listing is never guaranteed and timelines can change. Speak to our advisors for the latest status on Anglo-French Drugs & Industries Ltd.
Anglo-French Drugs & Industries Ltd unlisted shares have a face value of ₹10. Minimum quantities can vary with availability and deal size — our desk will confirm the current lot before you invest.
Unlisted share prices are not set by an exchange. The Anglo-French Drugs & Industries Ltd price reflects recent off-market deals, buyer/seller demand, the company's financials and expectations around a future IPO. Because it is over-the-counter, always confirm a live quote before transacting.
Unlisted shares like Anglo-French Drugs & Industries Ltd can offer pre-IPO upside but carry higher risk and lower liquidity than listed stocks, and there is no guaranteed exit. Invest only after reviewing the company's fundamentals and your risk profile — Safal Capital's SEBI-registered advisors can help you assess Anglo-French Drugs & Industries Ltd.
India's IPO pipeline hits Rs 3.86 lakh crore. What's driving the rush India Today
